ID
45143
Beschrijving
Principal Investigator: Mark A. Rubin, MD, Weill Cornell Medical College, New York, NY, USA MeSH: Prostatic Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000330 Seven primary prostate cancers and their paired normal counterparts were DNA-sequenced on a massively parallel sequencing platform. This approach was taken to investigate the genomes for mutations and genomic alterations that would be undetectable by lower-resolution methods. As result, tumors containing chains of balanced rearrangements that occurred within or adjacent to known cancer genes were discovered.
Link
Trefwoorden
Versies (3)
- 08-10-22 08-10-22 - Adrian Schulz
- 12-10-22 12-10-22 - Adrian Schulz
- 12-10-22 12-10-22 - Adrian Schulz
Houder van rechten
Mark A. Rubin, MD, Weill Cornell Medical College, New York, NY, USA
Geüploaded op
12 oktober 2022
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs000330 The Genomic Complexity of Primary Human Prostate Cancer
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject sources, consent form, and affection status of participants affected with prostate cancer.
- Sample ID, subject ID, and sample sources of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor sample characteristics, and demography of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor and normal blood sample characteristics, and subject ID of participants affected with prostate cancer.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject sources, consent form, and affection status of participants affected with prostate cancer.
- Sample ID, subject ID, and sample sources of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor sample characteristics, and demography of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor and normal blood sample characteristics, and subject ID of participants affected with prostate cancer.
C1512693 (UMLS CUI [1,2])